Free Express Shipping on Orders $450+ | Peptide of the Week: Tirzepatide - 10% Off This Week
Free Express Shipping on Orders $450+ | Peptide of the Week: Tirzepatide - 10% Off This Week
Melanotan 1 (MT1) and Melanotan 2 (MT2) are both synthetic melanocortin peptides, but they differ meaningfully in molecular structure, receptor selectivity, blood-brain barrier permeability, and research applications. This 2026 comparison guide covers the structural differences, melanocortin receptor profiles, research focus areas, and sourcing considerations for Canadian and US researchers studying the melanocortin system.
Melanotan 1 (MT1, afamelanotide-related, CAS 75921-69-6) is a linear synthetic melanocortin peptide studied primarily for selective MC1R interaction and pigmentation-related research. Melanotan 2 (MT2, CAS 121062-08-6) is a cyclic lactam analogue studied for broader melanocortin receptor engagement across MC1R, MC3R, and MC4R. The defining structural difference is MT2's cyclic conformation, which confers blood-brain barrier permeability and access to centrally located MC3R and MC4R receptors, expanding its research profile into neuroendocrine and metabolic pathway contexts.
Melanotan 1 (MT1) is a synthetic linear melanocortin peptide studied primarily for its selective interaction with the melanocortin-1 receptor (MC1R). It is related to afamelanotide-class compounds in the research literature and is associated with pigmentation-related signaling studies in controlled preclinical models.
Its linear structure limits blood-brain barrier permeability, confining its primary research activity to peripheral receptor pathways. This selectivity makes MT1 a more targeted tool for MC1R-specific research designs compared to the broader profile of MT2.
MT1 is a linear peptide studied for its selective interaction with the receptor responsible for pigmentation signaling. Because it does not readily cross the blood-brain barrier, its research activity stays at the peripheral level, making it a cleaner tool when researchers want to isolate MC1R pathway effects.
Melanotan 2 (MT2) is a synthetic cyclic lactam analogue of alpha-melanocyte-stimulating hormone (alpha-MSH). Its cyclic structure differentiates it fundamentally from MT1 and confers blood-brain barrier permeability, allowing it to interact with centrally located melanocortin receptors including MC3R and MC4R in addition to peripheral MC1R.
This broader receptor engagement makes MT2 more commonly referenced in multi-pathway melanocortin research, neuroendocrine studies, and comparative receptor activity investigations.
MT2's cyclic structure allows it to cross into the brain and interact with additional melanocortin receptors beyond MC1R. This broader receptor access is why MT2 appears more frequently in research involving appetite, energy balance, and neuroendocrine pathway modeling alongside pigmentation studies.
MT1 and MT2 share a common ancestor in alpha-MSH but differ structurally in ways that produce meaningfully different research profiles.
| Property | Melanotan 1 (MT1) | Melanotan 2 (MT2) |
|---|---|---|
| Full classification | Synthetic linear melanocortin peptide (afamelanotide-related) | Synthetic cyclic lactam analogue of alpha-MSH |
| CAS number | 75921-69-6 | 121062-08-6 |
| Structural conformation | Linear peptide chain | Cyclic lactam ring structure |
| Origin compound | Analogue derived from alpha-melanocyte-stimulating hormone (alpha-MSH) | Cyclic analogue derived from alpha-MSH with structural modifications for receptor stability |
| Blood-brain barrier permeability | Poor; primarily peripheral activity in research models | Yes; cyclic conformation facilitates CNS penetration in research models |
| Metabolic stability | Moderate stability; studied in depot formulations for extended activity | Greater conformational stability due to cyclic structure; more resistant to enzymatic degradation |
| Luxara Labs purity | ≥99% (third-party HPLC + MS) | ≥99% (third-party HPLC + MS) |
Understanding why MT1 and MT2 produce different research profiles requires understanding the receptor system they both act upon.
The melanocortin system consists of five G-protein-coupled receptors (MC1R through MC5R), each associated with distinct biological signaling pathways. MC1R is primarily associated with pigmentation and photoprotection signaling in peripheral skin tissue. MC3R and MC4R are expressed centrally in the brain and are associated with energy homeostasis, appetite regulation, and neuroendocrine signaling. MC2R is the ACTH receptor and is not a primary target of melanocortin peptide research. MC5R is associated with exocrine gland function.
| Receptor | Primary Location | Associated Research Context | MT1 Activity | MT2 Activity |
|---|---|---|---|---|
| MC1R | Melanocytes, skin, peripheral tissue | Pigmentation signaling, photoprotection research | Primary target | Active |
| MC2R | Adrenal cortex | ACTH receptor; not a primary melanocortin peptide target | Not a target | Not a target |
| MC3R | Brain (hypothalamus), peripheral tissue | Energy homeostasis, appetite signaling, metabolic pathway research | Minimal activity | Active (central) |
| MC4R | Brain (hypothalamus, brainstem) | Energy balance, neuroendocrine signaling, sexual function research | Minimal activity | Active (central) |
| MC5R | Exocrine glands, skin | Exocrine gland function research | Limited | Limited |
Receptor selectivity is the most important distinguishing feature between MT1 and MT2 for research design purposes.
| Research Dimension | Melanotan 1 (MT1) | Melanotan 2 (MT2) |
|---|---|---|
| Receptor selectivity | High selectivity toward MC1R | Broader engagement: MC1R, MC3R, MC4R |
| Primary receptor | MC1R (peripheral) | MC1R + MC3R + MC4R (peripheral and central) |
| Research emphasis | Pigmentation signaling, photoprotection pathway research, MC1R-specific models | Multi-pathway melanocortin research, neuroendocrine signaling, appetite and energy balance modeling |
| Research scope | Narrower; useful when MC1R isolation is the research objective | Broader; used in studies requiring multi-receptor melanocortin engagement |
| Literature volume | More targeted literature base focused on MC1R and pigmentation biology | Broader published literature covering melanocortin, neuroendocrine, and metabolic pathway research |
| Side-effect profile in research models | More limited; primarily MC1R-related activity | Broader; MC3R and MC4R engagement in central contexts produces additional signals that require accounting for in research design |
The most functionally significant difference between MT1 and MT2 is blood-brain barrier permeability, which is a direct consequence of their different structural conformations.
| Feature | Melanotan 1 (MT1) | Melanotan 2 (MT2) |
|---|---|---|
| Structural conformation | Linear peptide chain | Cyclic lactam ring structure |
| Blood-brain barrier crossing | Poor permeability; activity confined to peripheral tissue in research models | Good permeability; cyclic conformation enables CNS penetration in research models |
| Central receptor access | MC3R and MC4R are not accessible under standard conditions | MC3R and MC4R in the hypothalamus and brainstem are accessible |
| Research scope implications | Peripheral-only research design; pigmentation and photoprotection modeling | Peripheral and central research design; neuroendocrine, appetite, and metabolic pathway modeling in addition to pigmentation |
| Metabolic stability | Moderate; studied in depot and extended-release formulations in clinical research | Greater enzymatic stability due to cyclic structure; resistant to peptide bond cleavage |
| Complexity for research design | Lower; fewer receptor variables to account for | Higher; central receptor engagement requires additional experimental controls |
A complete head-to-head research reference for Melanotan 1 and Melanotan 2.
| Feature | Melanotan 1 (MT1) | Melanotan 2 (MT2) |
|---|---|---|
| CAS number | 75921-69-6 | 121062-08-6 |
| Structural type | Linear peptide | Cyclic lactam analogue |
| Derived from | Alpha-melanocyte-stimulating hormone (alpha-MSH) | Alpha-melanocyte-stimulating hormone (alpha-MSH) with cyclic modification |
| Primary receptor | MC1R | MC1R, MC3R, MC4R |
| Receptor selectivity | High (MC1R selective) | Low (multi-receptor agonist) |
| BBB permeability | Poor (peripheral activity) | Good (central + peripheral activity) |
| Central receptor access | No (MC3R/MC4R not accessed) | Yes (MC3R/MC4R in hypothalamus accessible) |
| Primary research focus | Pigmentation signaling, MC1R pathway research, photoprotection models | Multi-pathway melanocortin research, neuroendocrine signaling, appetite/energy balance modeling |
| Metabolic stability | Moderate; studied in depot formulations | Greater; cyclic structure resists enzymatic degradation |
| Research complexity | Lower; fewer receptor variables | Higher; central receptor engagement requires additional controls |
| Literature scope | More narrow; MC1R and pigmentation-focused | Broader; melanocortin, neuroendocrine, and metabolic pathway literature |
| Canadian regulatory status | Not approved for therapeutic use; research use only | Not approved for therapeutic use; research use only |
| Luxara Labs purity | ≥99% (third-party HPLC + MS) | ≥99% (third-party HPLC + MS) |
| Storage (lyophilized) | -20°C | -20°C |
| Post-reconstitution | 2-8°C | 2-8°C |
Both MT1 and MT2 require careful handling to maintain research-grade integrity. Purity and documentation standards are especially important for melanocortin peptides given regulatory sensitivity.
| Parameter | MT1 Standard | MT2 Standard |
|---|---|---|
| Lyophilized storage | -20°C; protect from light and moisture | -20°C; protect from light and moisture |
| Post-reconstitution storage | 2-8°C; use within research window | 2-8°C; use within research window |
| Freeze-thaw cycles | Minimize; degrade peptide integrity | Minimize; despite greater cyclic stability, repeated cycling still reduces reliability |
| Purity requirement | ≥99% with independent third-party HPLC and MS | ≥99% with independent third-party HPLC and MS |
| COA requirement | Batch-specific; lot number must match product received | Batch-specific; lot number must match product received |
| Domestic shipping advantage | No customs delays; faster transit; better temperature stability | No customs delays; faster transit; better temperature stability |
These pages extend the melanocortin receptor research context and broader comparison guide library.
These answers address the most common research questions about Melanotan 1 and Melanotan 2 from Canadian and US researchers in 2026.
The defining differences are structural conformation and receptor selectivity. MT1 is a linear peptide with high selectivity for MC1R, limited to peripheral activity due to poor blood-brain barrier permeability. MT2 is a cyclic lactam analogue that crosses the blood-brain barrier, enabling engagement with central MC3R and MC4R receptors in addition to peripheral MC1R. This structural difference is what drives MT2's broader research profile across neuroendocrine, appetite, and multi-pathway melanocortin studies.
The defining functional difference is blood-brain barrier permeability. MT1 is a linear peptide with poor BBB permeability, confining its research activity to peripheral pathways, primarily MC1R-mediated pigmentation and photoprotection signaling. MT2 is a cyclic lactam analogue that readily crosses the BBB, enabling researchers to study its central effects on MC3R and MC4R receptors, which are associated with appetite signaling, energy balance, and neuroendocrine pathways. This distinction determines which experimental questions each compound can answer.
MT1 binds selectively to MC1R with higher selectivity and relatively limited cross-reactivity at other melanocortin receptors. MT2 is a non-selective melanocortin agonist with activity at MC1R, MC3R, and MC4R. Because MC3R and MC4R are centrally located, MT2's engagement with these receptors is accessible only when blood-brain barrier penetration occurs, which its cyclic structure facilitates. MT1 cannot access these central receptors under standard research conditions.
MT2's cyclic lactam structure confers greater metabolic stability than MT1's linear chain. Cyclic peptides are generally more resistant to enzymatic degradation because protease access to peptide bonds is restricted by the ring conformation. MT1, as a linear peptide, is more susceptible to proteolytic cleavage in biological systems and has been studied in depot formulations to extend its activity window. In lyophilized research storage at -20 degrees Celsius, both compounds are stable under correct handling conditions.
MT2's wider experimental profile follows directly from its broader receptor engagement. By accessing MC3R and MC4R in addition to MC1R, MT2 activates signaling pathways involved in appetite regulation, energy balance, and neuroendocrine function alongside peripheral pigmentation pathways. This broader activation profile means MT2 introduces more receptor variables into a research design, which is why it requires more experimental controls and produces more diverse observed signals than MT1 in research models.
Neither MT1 nor MT2 is approved by Health Canada as a therapeutic product for human use. Both compounds are available strictly within a laboratory research framework for qualified researchers. Any supplier offering these compounds must label and position them as research-use-only materials in compliance with Canadian regulations. Researchers should review the Research Use Regulations Canada page for full compliance context.
All Luxara Labs peptides, including MT1 and MT2, are tested to a minimum of 99% purity by independent third-party HPLC and mass spectrometry analysis. A batch-specific Certificate of Analysis (COA) is available for every order, traceable to the specific lot received. Verification is performed by independent laboratories before any product is released. All products are labeled and positioned as research-use-only materials.
The following peer-reviewed publications and scientific resources support the melanocortin receptor, structural, and comparative content discussed on this page.
Join our list and get an instant 10% discount code — valid for first-time buyers.
